|
AU2019247751A1
|
|
Neurotoxins for use in inhibiting CGRP
|
|
US2019183987A1
|
|
Neurotoxins for use in minimizing scarring
|
|
CA3081462A1
|
|
Neurotoxin compositions for use in improving lung function
|
|
AU2018290765A1
|
|
Clostridial neurotoxin formulations and use
|
|
EP3615669A1
|
|
Botulinum neurotoxins production methods
|
|
AU2018254588A1
|
|
Initiating neurotoxin treatments
|
|
EP3612154A1
|
|
Botulinum neurotoxins for treating hyperhidrosis
|
|
AU2018237205A1
|
|
Botulinum neurotoxins for treating traumatic injuries
|
|
KR20190126894A
|
|
Botulinum neurotoxin for use in therapy
|
|
WO2018106339A1
|
|
Botulinum neurotoxins for use in tendon repair surgery
|
